Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Hancock Whitney (HWC)
NASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
$71.41-2.53%
Close 2026-11-05 · 1-day change
NASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
7.31 → 7.23 EPS · FY ending Dec 31, 2027 · 7 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 8 to 7; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for HWC yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Successful completion and integration of OFB Bancshares acquisition | The recent acquisition of OFB Bancshares should expand its market. | Improving | Acquisition fails or integration delays beyond FY26 | Regulatory approvals secured (Jul 2026); Q3 results show acquisition-driven growth HWC received regulatory approval for OFB Bancshares acquisition in July 2026; Q3 2026 slides cite acquisition-driven growth and expanding NIM. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
HWC is a financial-sector growth and execution story, rather than a clear turnaround. The long-term thesis is intact, with recent performance holding in the top half of its industry, but organic growth is only partly demonstrated because the latest loan and deposit increases included acquired balances.
Valuation is broadly aligned with the evidence, with a modest premium versus peers and an expectations gap that is slightly negative. The priced-in assessment is justified, and the fragility rating is low, so the evidence does not point to unusually stretched expectations.
Near term, the October earnings beat and improved efficiency ratio support the operating picture, though acquisition-related costs and balances make the underlying trend harder to judge. Over the multi-year view, growth depends on executing the organic plan and integrating One Florida Bank; systems conversion is expected in 2026-Q4. Risk is now moderate, and a guidance cut or a shift toward rate cuts could weigh on the business and sector backdrop.
The main favorable scenario is continued earnings strength and higher guidance from financial-sector peers, which could support sector momentum. The main risks are a guidance cut, lower rates, and execution problems during integration. Evidence on organic growth after acquired balances are separated remains limited.
For the next 1 to 3 years, HWC’s long-term thesis remains intact, but its strength depends on proving organic growth and completing integration while managing rate and guidance risks. Recent results are supportive, though the evidence is not strong enough to remove those execution questions. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| It pays a reliable dividend of $0.50 per share. |
| Intact |
| Dividend per share falls below $0.50 |
Dividend per share: $0.50 per share FY2026-Q2; GAAP. Published target: >=$0.50 per share. Target period is not explicitly aligned with this observation. Aug 6, 20260.5 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain profit margin with PE around 15.4 | A primary condition in Hancock Whitney's published investment case. The stated target is PE near 15.4. | Intact | PE falls below peer median 11.98 sustainably | P/E (TTM): 11.78x As of 2026-11-04; trailing twelve months. The target timing and basis require a separate assessment. Nov 4, 202611.7781 ratio · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue growth of about 6% per year | A primary condition in Hancock Whitney's published investment case. The stated target is >=5.7% YoY. | Intact | YoY revenue growth falls below ~5.7% next year | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$7.28 → $7.23 · observed estimates
$1.77B → $1.79B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $7.28 | $1,774,691,309 | 7 / 6 |
| 2026-07-25 | $7.29 | $1,774,692,080 | 10 / 8 |
| 2026-07-26 | $7.29 | $1,763,260,770 | 10 / 8 |
| 2026-07-27 | $7.29 | $1,763,260,770 | 10 / 8 |
| 2026-07-28 | $7.28 | $1,774,691,309 | 7 / 6 |
| 2026-07-29 | $7.29 | $1,774,692,080 | 10 / 8 |
| 2026-07-30 | $7.29 | $1,763,260,770 | 10 / 8 |
| 2026-07-31 | $7.29 | $1,763,260,770 | 10 / 8 |
| 2026-08-01 | $7.28 | $1,774,691,309 | 7 / 6 |
| 2026-08-02 | $7.28 | $1,774,691,309 | 7 / 6 |
| 2026-08-03 | $7.29 | $1,774,692,080 | 10 / 8 |
| 2026-08-04 | $7.29 | $1,774,692,080 | 10 / 8 |
| 2026-08-05 | $7.28 | $1,774,691,309 | 7 / 6 |
| 2026-08-06 | $7.29 | $1,774,692,080 | 10 / 8 |
| 2026-08-07 | $7.28 | $1,774,691,309 | 7 / 6 |
| 2026-08-08 | $7.28 | $1,774,691,309 | 7 / 6 |
| 2026-08-09 | $7.28 | $1,774,691,309 | 7 / 6 |
| 2026-08-10 | $7.29 | $1,774,692,080 | 10 / 8 |
| 2026-08-12 | $7.29 | $1,774,692,080 | 10 / 8 |
| 2026-08-13 | $7.28 | $1,774,691,309 | 7 / 6 |
| 2026-08-14 | $7.28 | $1,774,691,309 | 7 / 6 |
| 2026-08-15 | $7.28 | $1,774,691,309 | 7 / 6 |
| 2026-08-16 | $7.28 | $1,774,691,309 | 7 / 6 |
| 2026-08-17 | $7.28 | $1,774,691,309 | 7 / 6 |
| 2026-08-18 | $7.28 | $1,774,691,309 | 7 / 6 |
| 2026-08-19 | $7.28 | $1,774,691,309 | 7 / 6 |
| 2026-08-20 | $7.28 | $1,774,691,309 | 7 / 6 |
| 2026-08-21 | $7.28 | $1,774,691,309 | 7 / 6 |
| 2026-08-22 | $7.28 | $1,774,691,309 | 7 / 6 |
| 2026-08-23 | $7.28 | $1,774,691,309 | 7 / 6 |
| 2026-08-24 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-08-25 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-08-26 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-08-27 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-08-28 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-08-29 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-08-30 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-08-31 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-09-01 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-09-02 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-09-03 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-09-04 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-09-05 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-09-06 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-09-07 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-09-08 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-09-09 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-09-10 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-09-11 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-09-12 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-09-13 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-09-14 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-09-15 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-09-16 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-09-17 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-09-18 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-09-19 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-09-20 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-09-21 | $7.30 | $1,774,691,309 | 7 / 6 |
| 2026-09-22 | $7.31 | $1,777,541,777 | 7 / 6 |
| 2026-09-23 | $7.30 | $1,777,757,027 | 7 / 6 |
| 2026-09-24 | $7.30 | $1,777,757,027 | 7 / 6 |
| 2026-09-25 | $7.30 | $1,777,757,027 | 7 / 6 |
| 2026-09-26 | $7.30 | $1,777,757,027 | 7 / 6 |
| 2026-09-27 | $7.30 | $1,777,757,027 | 7 / 6 |
| 2026-09-28 | $7.30 | $1,777,757,027 | 7 / 6 |
| 2026-09-29 | $7.30 | $1,777,757,027 | 7 / 6 |
| 2026-09-30 | $7.30 | $1,777,757,027 | 7 / 6 |
| 2026-10-01 | $7.30 | $1,777,757,027 | 8 / 6 |
| 2026-10-02 | $7.31 | $1,779,482,027 | 8 / 6 |
| 2026-10-03 | $7.31 | $1,779,482,027 | 8 / 6 |
| 2026-10-04 | $7.31 | $1,779,482,027 | 8 / 6 |
| 2026-10-05 | $7.31 | $1,779,482,027 | 8 / 6 |
| 2026-10-06 | $7.32 | $1,779,482,027 | 8 / 6 |
| 2026-10-07 | $7.32 | $1,779,482,027 | 8 / 6 |
| 2026-10-08 | $7.32 | $1,779,482,027 | 8 / 6 |
| 2026-10-09 | $7.32 | $1,779,482,027 | 7 / 6 |
| 2026-10-10 | $7.32 | $1,779,482,027 | 7 / 6 |
| 2026-10-11 | $7.32 | $1,779,482,027 | 7 / 5 |
| 2026-10-12 | $7.32 | $1,779,482,027 | 7 / 5 |
| 2026-10-13 | $7.32 | $1,779,482,027 | 7 / 5 |
| 2026-10-14 | $7.32 | $1,779,482,027 | 7 / 5 |
| 2026-10-15 | $7.32 | $1,779,482,027 | 7 / 5 |
| 2026-10-16 | $7.32 | $1,779,482,027 | 7 / 6 |
| 2026-10-17 | $7.32 | $1,779,482,027 | 7 / 6 |
| 2026-10-18 | $7.32 | $1,779,482,027 | 7 / 6 |
| 2026-10-19 | $7.32 | $1,779,482,027 | 7 / 6 |
| 2026-10-20 | $7.32 | $1,779,482,027 | 7 / 6 |
| 2026-10-21 | $7.27 | $1,782,095,302 | 7 / 6 |
| 2026-10-22 | $7.27 | $1,788,059,677 | 7 / 6 |
| 2026-10-23 | $7.26 | $1,788,441,421 | 7 / 6 |
| 2026-10-24 | $7.26 | $1,788,441,421 | 7 / 6 |
| 2026-10-25 | $7.26 | $1,788,441,421 | 7 / 6 |
| 2026-10-26 | $7.26 | $1,788,441,421 | 7 / 6 |
| 2026-10-27 | $7.26 | $1,788,441,421 | 7 / 6 |
| 2026-10-28 | $7.26 | $1,788,441,421 | 7 / 6 |
| 2026-10-29 | $7.23 | $1,788,441,421 | 7 / 6 |
| 2026-10-30 | $7.23 | $1,788,441,421 | 7 / 6 |
| 2026-10-31 | $7.23 | $1,788,441,421 | 7 / 6 |
| 2026-11-01 | $7.23 | $1,787,461,624 | 7 / 6 |
| 2026-11-02 | $7.23 | $1,787,461,624 | 7 / 6 |
| 2026-11-03 | $7.23 | $1,787,461,624 | 7 / 6 |
| 2026-11-04 | $7.23 | $1,787,461,624 | 7 / 6 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 7 Buy / Strong Buy · 3 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 2 recorded
1 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.